Citadel Advisors - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$7,598,684
-68.1%
279,981
-63.9%
0.00%
-50.0%
Q2 2023$23,850,305
-45.5%
775,872
-36.2%
0.00%
-60.0%
Q1 2023$43,789,205
+79.2%
1,215,354
+96.5%
0.01%
+66.7%
Q4 2022$24,440,749
+1.7%
618,440
+3.4%
0.01%0.0%
Q3 2022$24,030,000
+7.4%
598,061
+12.3%
0.01%0.0%
Q2 2022$22,384,000
-66.5%
532,445
-68.9%
0.01%
-57.1%
Q1 2022$66,744,000
+418.9%
1,713,133
+430.7%
0.01%
+366.7%
Q4 2021$12,863,000
+48.1%
322,781
+34.3%
0.00%
+50.0%
Q3 2021$8,687,000
-68.8%
240,379
-64.6%
0.00%
-66.7%
Q2 2021$27,834,000
+101.2%
679,051
+114.1%
0.01%
+100.0%
Q1 2021$13,836,000
-53.1%
317,205
-46.2%
0.00%
-62.5%
Q4 2020$29,497,000
+514.4%
589,341
+416.3%
0.01%
+700.0%
Q3 2020$4,801,000
-89.5%
114,149
-87.9%
0.00%
-93.8%
Q2 2020$45,729,000941,9050.02%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2020
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders